AJCC	American Joint Committee on Cancer
AUC	Areas Under Curves
BCBM	Breast Cancer Brain Metastasis
cfmiR	Cell-free miR
cfDNA	Cell-free DNA
cfNA	Cell-free Nucleic Acids
CII	Checkpoint Inhibitor Immunotherapy
CLIA	Clinical Laboratory Improvement Amendments
dNTP	Deoxyribonucleotide Triphosphate
EDTA	Ethylenediamine Tetraacetic Acid
IRAE	Immune-Related Adverse Events
DE	Differentially Expressed
FC	Fold-Change
FDA	Food and Drug Adminstration
FDR	False Discovery Rate
FFPE	Formalin-Fixed Paraffin-Embedded
GBM	Glioblastoma
GEO	Gene Expression Omnibus
H&E	Hematoxylin & Eosin
LuBM	Lung Cancer Brain Metastasis
MBM	Melanoma Brain Metastasis
miR	MicroRNA
PCA	Principal Component Analysis
PC	Principal Components
PCR	Polymerase Chain Reaction
QC	Quality Check
NS	Non Significant
RECIST	Response Evaluation Criteria In Solid Tumors 1.1
REMARK	Reporting Recommendations For Tumour Marker
ROC	Receiver Operating Characteristic
RT	Room Temperature
SD	Standard Deviation
sLDH	Serum Lactate Dehydrogenase
WTA	Whole Transcriptome Assay